Initial validation of a novel pre-screening tool for HIV-associated CNS impairment: The Virtual Driving and CNS Assessment System (VDCA)
Initial validation of a novel pre-screening tool for HIV-associated CNS impairment: The Virtual Driving and CNS Assessment System (VDCA)
批准号:
10474765
负责人:
Venkatesh Kandadai
金额:
$7.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-04 至 2022-12-31
关键词:
Acquired Immunodeficiency SyndromeActivities of Daily LivingAreaAutomobile DrivingAwardClinicalCodeDataDetectionDevelopmentDiagnosisDiagnostic testsDiseaseEarly DiagnosisEtiologyEvaluationFunctional Magnetic Resonance ImagingFutureGoalsHIVHIV diagnosisHuman ResourcesHuman immunodeficiency virus testImpaired cognitionImpairmentIndividualLinkLongitudinal cohortMagnetoencephalographyMeasuresMedicalMemoryMethodsMotorNational Institute of Mental HealthNeurocognitive DeficitNeurologicNeuropathogenesisOutpatientsParentsParticipantPathogenesisPatientsPerformancePersonsPhaseProceduresProtocols documentationQuality of lifeResearchResearch Domain CriteriaResearch PriorityResource-limited settingResourcesRiskScreening procedureSmall Business Innovation Research GrantStandardizationSystemTestingTrainingValidationWorkbasecognitive controlcognitive systemcognitive taskcostearly screeningefficacy studyfrontal lobefunctional disabilityimaging studyimpaired driving performanceimprovedinsightinterestneuroAIDSneuroimagingnovelphase 2 studyprogramsscreeningsensorimotor systemvirtual
中文摘要
项目摘要和摘要
检测HIV相关中枢神经系统损害(HIVCI)的标准范例涉及以下方案
需要训练有素的人员,这些人员通常不切实际,在典型的门诊环境中无法获得。结果,
HIVCI通常未被发现或发现较晚,导致生活质量下降和存活率下降。与
需要更早的检测和新的医疗账单代码的可用性,最近推动改变
将认知障碍的早期筛查作为诊断测试的先兆的范例目前正在进行
正在进行中;然而,其能力和范围受到严重限制。因此,迫切需要使
这种在病程早期检测HIVCI的新范式(NIMH部门感兴趣的一个主题领域
艾滋病研究和艾滋病毒神经发病计划):普遍筛查(不需要训练有素的工作人员)
可靠地将艾滋病毒阳性患者转介到神经心理测验(NP)诊断测试(由训练有素的工作人员进行)。这款SBIR
提出了一种新的价值主张:基于已知函数的通用筛选工具
损伤--驾驶。因此,这个SBIR的长期目标是一个新的虚拟驾驶和CNS
评估系统(VDCA)作为一种有效、低成本、易于管理、普遍适用的筛查系统
HIV阳性患者。为了实现这些目标和发展VDCA,我们将利用(1)我们的
商业上成功的虚拟驾驶测试(VDT)作为开发VDCA的平台;(2)我们团队的
利用驾驶来完成认知、感觉运动和记忆系统的科学知识(包括
(3)我们独家接触到已建立的HIV+参与者纵向队列;以及(4)
检测HIVCI发病机制的新神经影像方法。我们的初步工作是使用
脑磁图(Meg)支持VDCA作为一种有意义的认知探查的发展。
控制和功能能力将成为HIVCI的通用屏幕。在本副刊中,我们建议
在父母SBIR奖的成功工作的基础上,在追求
较大的第二阶段项目:目标1:进行可行性成像研究,以量化HIVCI的发病机制
用VDCA表现来衡量额叶皮质的执行网络。这些见解将提供
支持VDCA作为通用屏幕的实用性和可行性,并为未来设定方向
第二阶段的提炼、测试和评估。
英文摘要
Project Summary and Abstract
The standard paradigm for the detection of HIV-associated CNS impairment (HIVCI) involves protocols that
require trained personnel, often impractical and unavailable in typical outpatient clinical settings. As a result,
HIVCI is often undetected or detected late, leading to a lower quality of life and decreased survival. With the
need for earlier detection and the availability of new medical billing codes, a recent push to change the
paradigm towards earlier screening of cognitive impairment as a precursor to diagnostic testing is currently
underway; however, severely limited in its capability and scope. Therefore, there is an urgent need to enable
this new paradigm to detect HIVCI earlier in the disease course (a topic area of interest to NIMH’s Division
of AIDS Research and HIV Neuropathogenesis Program): universal screening (not requiring trained staff) to
reliably refer HIV+ patients to neuropsychometric (NP) diagnostic testing (by trained staff). This SBIR
proposes a novel value proposition: A universal screening tool based on a known functional
impairment - driving. Thus, the long-term goal of this SBIR is a new Virtual Driving and CNS
Assessment System (VDCA) as a valid, low cost, easy-to-administer, universal screening system for
HIV+ patients. To achieve these objectives and develop the VDCA, we will leverage (1) our
commercially-successful virtual driving test (VDT) as a platform on which to develop the VDCA; (2) our team’s
scientific know-how in utilizing driving to task cognitive, sensorimotor and memory systems (including those
implicated in HIVCI); (3) our exclusive access to an established longitudinal cohort of HIV+ participants; and (4)
novel neuroimaging methods to detect HIVCI pathogenesis. Our preliminary work using
magnetoencephalography (MEG) supports the development of the VDCA as a meaningful probe of cognitive
control and functional capacity that will become a universal screen for HIVCI. In this supplement, we propose
one additional aim building off of the successful work conducted in parent SBIR award, before pursuing a
larger Phase II project: Aim 1: Conduct a feasibility imaging study to quantify HIVCI pathogenesis in the
executive network of the frontal cortex as measured by VDCA performance. These insights will provide
support for the utility and feasibility of the VDCA as a universal screen and set the direction for future
refinement, testing and evaluation in Phase II.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fnins.2022.912766
发表时间:
2022
期刊:
FRONTIERS IN NEUROSCIENCE
影响因子:
4.3
作者:
[Grethlein, David, Pirrone, Vanessa, Devlin, Kathryn N., Dampier, Will, Szep, Zsofia, Winston, Flaura K., Ontanon, Santiago, Walshe, Elizabeth A., Malone, Kim, Tillman, Shinika, Ances, Beau M., Kandadai, Venk, Kolson, Dennis L., Wigdahl, Brian]
通讯作者:
Wigdahl, Brian
Initial validation of a novel pre-screening tool for HIV-associated CNS impairment: The Virtual Driving and CNS Assessment System (VDCA)
-
批准号:10426510
-
项目类别:
-
资助金额:$5.49万
-
财政年份:2021
-
负责人:Venkatesh Kandadai
-
依托单位:
Initial validation of a novel pre-screening tool for HIV-associated CNS impairment: The Virtual Driving and CNS Assessment System (VDCA)
-
批准号:10080545
-
项目类别:
-
资助金额:$25.52万
-
财政年份:2020
-
负责人:Venkatesh Kandadai
-
依托单位:
海外基金